UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049770
Receipt number R000056686
Scientific Title Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor treated by carbon ion radiotherapy, Mid- to long-term follow-up study
Date of disclosure of the study information 2022/12/14
Last modified on 2022/12/14 09:33:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor treated by carbon ion radiotherapy, Mid- to long-term follow-up study

Acronym

Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor treated by carbon ion radiotherapy, Mid- to long-term follow-up study

Scientific Title

Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor treated by carbon ion radiotherapy, Mid- to long-term follow-up study

Scientific Title:Acronym

Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor treated by carbon ion radiotherapy, Mid- to long-term follow-up study

Region

Japan


Condition

Condition

Liver tumor

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To explore methods and predictive value factors for assessing hepatic reserve in the mid-to-long term after heavy ion therapy for liver tumors using GSA SPECT and MRI.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Assessment of diagnostic abilities of GSA SPECT or MRI in terms of prediction of residual liver reserve capacity before and 3 months, 1 to 5 years after carbon ion radiotherapy

Key secondary outcomes

Correlation among overall survival rate, treatment completion rate in intent to treat group, liver function indices such as Child-Pugh classification and other clinical data, and radiation dosimetry estimation.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients underwent GSA SPECT and MRI among those who were / will be treated with carbon ion radiotherapy for liver tumors from December 2018 to September 2024 at QST hospital.

Key exclusion criteria

Patients who refuse to participate in this study. However, if the request is made after the opt-out period and the data has already been used for analysis, it may not be excluded.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Kana
Middle name
Last name Yamzaki

Organization

Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST)

Division name

Dept. of Molecular Imaging and Theranostics

Zip code

263-8555

Address

4-9-1 Anagawa, Inage-ku, Chiba, Japan

TEL

043-206-3402

Email

yamazaki.kana@qst.go.jp


Public contact

Name of contact person

1st name Kana
Middle name
Last name Yamazaki

Organization

Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Instit

Division name

Dept. of Molecular Imaging and Theranostics

Zip code

263-8555

Address

4-9-1 Anagawa, Inage-ku, Chiba, Japan

TEL

043-206-3402

Homepage URL


Email

yamazaki.kana@qst.go.jp


Sponsor or person

Institute

Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST)

Institute

Department

Personal name



Funding Source

Organization

Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Certifi ed Review Board, QST

Address

4-9-1 Anagawa, Inage-ku, Chiba, Japan

Tel

043-206-4706

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 06 Day

Date of IRB

2022 Year 12 Month 06 Day

Anticipated trial start date

2022 Year 12 Month 14 Day

Last follow-up date

2026 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2022 Year 12 Month 13 Day

Last modified on

2022 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056686


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name